328 related articles for article (PubMed ID: 33053469)
1. Engineered regulatory T cells expressing myelin-specific chimeric antigen receptors suppress EAE progression.
De Paula Pohl A; Schmidt A; Zhang AH; Maldonado T; Königs C; Scott DW
Cell Immunol; 2020 Dec; 358():104222. PubMed ID: 33053469
[TBL] [Abstract][Full Text] [Related]
2. Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells.
Kim YC; Zhang AH; Yoon J; Culp WE; Lees JR; Wucherpfennig KW; Scott DW
J Autoimmun; 2018 Aug; 92():77-86. PubMed ID: 29857928
[TBL] [Abstract][Full Text] [Related]
3. Treatment of experimental autoimmune encephalomyelitis with engineered bi-specific Foxp3+ regulatory CD4+ T cells.
Malviya M; Saoudi A; Bauer J; Fillatreau S; Liblau R
J Autoimmun; 2020 Mar; 108():102401. PubMed ID: 31948790
[TBL] [Abstract][Full Text] [Related]
4. A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4
Moorman CD; Curtis AD; Bastian AG; Elliott SE; Mannie MD
Front Immunol; 2018; 9():3119. PubMed ID: 30687323
[TBL] [Abstract][Full Text] [Related]
5. CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery.
Fransson M; Piras E; Burman J; Nilsson B; Essand M; Lu B; Harris RA; Magnusson PU; Brittebo E; Loskog AS
J Neuroinflammation; 2012 May; 9():112. PubMed ID: 22647574
[TBL] [Abstract][Full Text] [Related]
6. IFN-β Facilitates Neuroantigen-Dependent Induction of CD25+ FOXP3+ Regulatory T Cells That Suppress Experimental Autoimmune Encephalomyelitis.
Wang D; Ghosh D; Islam SM; Moorman CD; Thomason AE; Wilkinson DS; Mannie MD
J Immunol; 2016 Oct; 197(8):2992-3007. PubMed ID: 27619998
[TBL] [Abstract][Full Text] [Related]
7. CD4
Fu RY; Chen AC; Lyle MJ; Chen CY; Liu CL; Miao CH
Cell Immunol; 2020 Dec; 358():104216. PubMed ID: 32987195
[TBL] [Abstract][Full Text] [Related]
8. A GM-CSF-neuroantigen tolerogenic vaccine elicits inefficient antigen recognition events below the CD40L triggering threshold to expand CD4
Moorman CD; Bastian AG; DeOca KB; Mannie MD
J Neuroinflammation; 2020 Jun; 17(1):180. PubMed ID: 32522287
[TBL] [Abstract][Full Text] [Related]
9. The in vivo and in vitro induction of anterior chamber associated immune deviation to myelin antigens in C57BL/6 mice.
Farooq SM; Elkhatib WF; Ashour HM
Brain Behav Immun; 2014 Nov; 42():118-22. PubMed ID: 24953428
[TBL] [Abstract][Full Text] [Related]
10. Involvement of regulatory T cells in the experimental autoimmune encephalomyelitis-preventive effect of dendritic cells expressing myelin oligodendrocyte glycoprotein plus TRAIL.
Hirata S; Matsuyoshi H; Fukuma D; Kurisaki A; Uemura Y; Nishimura Y; Senju S
J Immunol; 2007 Jan; 178(2):918-25. PubMed ID: 17202353
[TBL] [Abstract][Full Text] [Related]
11. Redirecting therapeutic T cells against myelin-specific T lymphocytes using a humanized myelin basic protein-HLA-DR2-zeta chimeric receptor.
Moisini I; Nguyen P; Fugger L; Geiger TL
J Immunol; 2008 Mar; 180(5):3601-11. PubMed ID: 18292588
[TBL] [Abstract][Full Text] [Related]
12. Discrete TCR repertoires and CDR3 features distinguish effector and Foxp3+ regulatory T lymphocytes in myelin oligodendrocyte glycoprotein-induced experimental allergic encephalomyelitis.
Nguyen P; Liu W; Ma J; Manirarora JN; Liu X; Cheng C; Geiger TL
J Immunol; 2010 Oct; 185(7):3895-904. PubMed ID: 20810983
[TBL] [Abstract][Full Text] [Related]
13. Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance.
Zhang Q; Lu W; Liang CL; Chen Y; Liu H; Qiu F; Dai Z
Front Immunol; 2018; 9():2359. PubMed ID: 30369931
[TBL] [Abstract][Full Text] [Related]
14. A Spontaneous Model of Experimental Autoimmune Encephalomyelitis Provides Evidence of MOG-Specific B Cell Recruitment and Clonal Expansion.
Salvador F; Deramoudt L; Leprêtre F; Figeac M; Guerrier T; Boucher J; Bas M; Journiac N; Peters A; Mars LT; Zéphir H
Front Immunol; 2022; 13():755900. PubMed ID: 35185870
[TBL] [Abstract][Full Text] [Related]
15. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
[TBL] [Abstract][Full Text] [Related]
16. Immune tolerance induced by intravenous transfer of immature dendritic cells via up-regulating numbers of suppressive IL-10(+) IFN-γ(+)-producing CD4(+) T cells.
Zhou F; Ciric B; Zhang GX; Rostami A
Immunol Res; 2013 May; 56(1):1-8. PubMed ID: 23292714
[TBL] [Abstract][Full Text] [Related]
17. Regulatory T Cell Dysfunction Acquiesces to BTLA+ Regulatory B Cells Subsequent to Oral Intervention in Experimental Autoimmune Encephalomyelitis.
Huarte E; Jun S; Rynda-Apple A; Golden S; Jackiw L; Hoffman C; Maddaloni M; Pascual DW
J Immunol; 2016 Jun; 196(12):5036-46. PubMed ID: 27194787
[TBL] [Abstract][Full Text] [Related]
18. Curing CNS autoimmune disease with myelin-reactive Foxp3+ Treg.
Stephens LA; Malpass KH; Anderton SM
Eur J Immunol; 2009 Apr; 39(4):1108-17. PubMed ID: 19350586
[TBL] [Abstract][Full Text] [Related]
19. Precision Engineering of an Anti-HLA-A2 Chimeric Antigen Receptor in Regulatory T Cells for Transplant Immune Tolerance.
Muller YD; Ferreira LMR; Ronin E; Ho P; Nguyen V; Faleo G; Zhou Y; Lee K; Leung KK; Skartsis N; Kaul AM; Mulder A; Claas FHJ; Wells JA; Bluestone JA; Tang Q
Front Immunol; 2021; 12():686439. PubMed ID: 34616392
[TBL] [Abstract][Full Text] [Related]
20. Towards antigen-specific Tregs for type 1 diabetes: Construction and functional assessment of pancreatic endocrine marker, HPi2-based chimeric antigen receptor.
Radichev IA; Yoon J; Scott DW; Griffin K; Savinov AY
Cell Immunol; 2020 Dec; 358():104224. PubMed ID: 33068914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
